In NHL, it has been documented that the overexpression of anti-apoptotic proteins Bcl-2 (13, 14), Bcl-XL (15, 16), and Mcl-1 (62) is associated to drug-resistant profile. The gene discussed is BCL2L1; the disease is non-Hodgkin lymphoma.